Christopher M Rhodes

US Patent:

20080200383, Aug 21, 2008

Filed:

Apr 6, 2006

Appl. No.:

11/910723

Inventors:

Robert N. Jennings - San Diego CA, US
John T.H. Ong - San Marcos CA, US
Christopher A. Rhodes - San Diego CA, US
Gregg Stetsko - Incline Village NV, US
Steven J. Prestrelski - San Diego CA, US

Assignee:

Amylin Pharmaceuticals, Inc. - San Diego CA

International Classification:

A61K 38/22
A61P 3/10

US Classification:

514 12

Abstract:

The present disclosure is directed to stable pharmaceutical formulations and uses thereof.

US Patent:

20090069226, Mar 12, 2009

Filed:

Jan 12, 2005

Appl. No.:

11/628123

Inventors:

John Ong - San Diego CA, US
Robert Jennings - San Diego CA, US
Christopher Rhodes - San Diego CA, US
Gregg Stetsko - San Diego CA, US

Assignee:

Amylin Pharmaceuticals, Inc. - San Diego CA

International Classification:

A61K 38/17
A61K 38/02

US Classification:

514 12, 514 2

Abstract:

Provided are methods and compositions for enhancing the transmucosal absorption of bioactive peptides and proteins. More particularly, the invention provides compositions for enhancing the transmucosal absorption of bioactive peptides and proteins, such as exendin-4, PYY, PYY3-36, and GLP-1 and their analogs and derivatives, wherein the compositions comprise an absorption enhancing mixture of a cationic polyamino acid, at least one additional absorption enhancing agent, and a buffer that is compatible with the polyamino acid. Also provided are methods for enhancing the transmucosal absorption and bioavailability of bioactive peptides and proteins using such compositions.

US Patent:

20220354782, Nov 10, 2022

Filed:

Sep 16, 2020

Appl. No.:

17/760596

Inventors:

- Franklin TN, US
Lawrence D'Souza - San Diego CA, US
Christopher A. Rhodes - San Diego CA, US

International Classification:

A61K 9/00
A61K 47/54
A61K 38/28
A61K 38/26
A61K 47/10
A61K 47/22

Abstract:

Provided are ultra fast-acting subcutaneously injectable insulin formulations as well as a stabilized subcutaneously injectable insulin and glucagon formulations, in addition to injection systems and methods of treatments and use thereof.

US Patent:

20190381093, Dec 19, 2019

Filed:

Jul 19, 2017

Appl. No.:

16/088992

Inventors:

- Carlsbad CA, US
David C. LITZINGER - Poway CA, US
Christopher RHODES - San Diego CA, US
Andrew M. CERRO - Alisa Viejo CA, US

International Classification:

A61K 33/18
A61K 9/06
A61K 9/00
A61K 47/10
A61P 31/04

Abstract:

This invention relates generally to an emollient topical composition of matter that contains molecular iodine with a reduced effective vapor pressure. In specific embodiments, the composition reduces the loss of molecular iodine to the atmosphere under storage conditions after application to mammalian tissue.

US Patent:

20160120950, May 5, 2016

Filed:

Oct 30, 2015

Appl. No.:

14/927954

Inventors:

- Wilmington DE, US
Christopher A. Rhodes - San Diego CA, US
Gregg Stetsko - San Diego CA, US
Steven J. Prestrelski - San Diego CA, US

Assignee:

Amylin Pharmaceuticals, LLC - Wilmington DE
AstraZeneca Pharmaceuticals LP - Wilmington DE

International Classification:

A61K 38/22
A61K 47/20
A61K 9/08

Abstract:

The present disclosure is directed to stable pharmaceutical formulations and uses thereof.

US Patent:

20150157725, Jun 11, 2015

Filed:

Dec 15, 2014

Appl. No.:

14/570295

Inventors:

- San Diego CA, US
- Wilmington DE, US
Christopher RHODES - San Diego CA, US
Gregg STETSKO - San Diego CA, US

International Classification:

A61K 47/34
A61K 47/38
A61K 47/02
A61K 38/22
A61K 47/18

Abstract:

Provided are methods and compositions for enhancing the transmucosal absorption of bioactive peptides and proteins. More particularly, the invention provides compositions for enhancing the transmucosal absorption of bioactive peptides and proteins, such as exendin-4, PYY, PYY3-36, and GLP-1 and their analogs and derivatives, wherein the compositions comprise an absorption enhancing mixture of a cationic polyamino acid, at least one additional absorption enhancing agent, and a buffer that is compatible with the polyamino acid. Also provided are methods for enhancing the transmucosal absorption and bioavailability of bioactive peptides and proteins using such compositions.

US Patent:

20150111824, Apr 23, 2015

Filed:

Oct 28, 2014

Appl. No.:

14/525930

Inventors:

- San Diego CA, US
- Wilmington DE, US
Christopher A. RHODES - San Diego CA, US
Gregg STETSKO - Incline Village NV, US
Steven J. PRESTRELSKI - San Diego CA, US

International Classification:

A61K 47/22
A61K 47/14
A61K 47/18
A61K 38/22
A61K 47/20

US Classification:

514 97

Abstract:

The present disclosure is directed to stable pharmaceutical formulations and uses thereof.